← Back to Bills
S.Res. 696Senate119th Congress (2025-2027)Passed Congress

A resolution expressing support for the designation of the month of April 2026 as "Parkinson's Awareness Month".

Sponsored by Rick ScottSen. Rick Scott (R-FL)
Introduced April 28, 2026

AI-Generated Summary

Updated April 30, 2026 at 4:53 AM UTC

The Senate resolution expresses its support for naming April 2026 "Parkinson's Awareness Month." It highlights the impact of Parkinson's disease in the United States and calls for continued research, education, and community support for those affected and their families.

Key Provisions

  • The Senate formally supports designating April 2026 as Parkinson's Awareness Month.
  • It endorses the goals of the awareness month, including raising public knowledge and supporting those living with the disease.
  • The resolution reaffirms support for research aimed at better treatments and a cure for Parkinson's disease.
  • It recognizes individuals who take part in clinical trials that advance understanding of the disease.
  • The Senate commends the work of organizations, volunteers, researchers, and others who improve the quality of life for people with Parkinson's and their families.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

SenateFloor Latest Action

Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S2076-2077; text: CR S2085-2086)

April 28, 2026

Floor Debate

1 member

What members said about S.Res. 696 on the floor

1 Republican
Cynthia M. Lummis
Sen. Cynthia M. LummisR-WY · Apr 28, 2026

Mr. President, I ask unanimous consent that the Senate now proceed on the en bloc consideration of the following resolutions, which are at the desk: S. Res. 692, S. Res. 693, S. Res. 694, S. Res.…

Record

Bill Text

Latest available legislative text

Reading Mode
Latest
Raw Text PDF XML
Agreed to SenateIssued April 28, 2026

III

119th CONGRESS

2d Session

S. RES. 696

IN THE SENATE OF THE UNITED STATES

April 28, 2026

Mr. Scott of Florida (for himself, Mr. Booker, and Mr. Risch) submitted the following resolution; which was considered and agreed to

RESOLUTION

Expressing support for the designation of the month of April 2026 as Parkinson’s Awareness Month.

Whereas Parkinson’s disease—

(1)

affects over 1,000,000 individuals in the United States with nearly 90,000 individuals diagnosed each year;

(2)

is the fastest-growing and second most common neurodegenerative disease in the world;

(3)

is believed to be caused by a combination of genetic and environmental factors, but the exact cause in most individuals is still unknown; and

(4)

is the 13th leading cause of death in the United States, according to the Centers for Disease Control and Prevention;

Whereas the symptoms of Parkinson’s disease can include dementia and cognitive impairment, tremors, slowness of movement and rigidity, gait and balance difficulties, speech and swallowing difficulties, depression, and a variety of other symptoms;

Whereas there are millions of family caregivers, friends, and loved ones whose lives are greatly affected by Parkinson’s disease; and

Whereas more research, education, and community support services are needed—

(1)

to find better treatments and a cure for Parkinson’s disease; and

(2)

to maintain the dignity of individuals living with Parkinson's disease: Now, therefore, be it

That the Senate—

(1)

expresses support for the designation of the month of April 2026 as Parkinson’s Awareness Month;

(2)

supports the goals and ideals of Parkinson’s Awareness Month;

(3)

continues to support research to find better treatments and a cure for Parkinson’s disease;

(4)

recognizes the individuals living with Parkinson’s disease who participate in vital clinical trials to advance the knowledge of the disease; and

(5)

commends the dedication of organizations, volunteers, researchers, and millions of individuals across the United States working to improve the quality of life of people living with Parkinson’s disease and their families.